D-Index & Metrics Best Publications
Carl Urban

Carl Urban

Weill Cornell Medicine
United States

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Bacteria
  • Internal medicine

His primary areas of study are Microbiology, Drug resistance, Imipenem, Klebsiella and Acinetobacter baumannii. His Microbiology study frequently links to related topics such as DNA gyrase. His Drug resistance study combines topics in areas such as Klebsiella pneumoniae and Enterobacteriaceae.

His research investigates the link between Imipenem and topics such as Polymyxin B that cross with problems in Amikacin, Polymyxin, Rifampicin and Neisseriaceae. His Klebsiella study incorporates themes from Antibacterial agent, Infection control, Cephalosporin Resistance, Cephalosporin Antibiotic and Carbapenem. His Antibiotic resistance research incorporates elements of Molecular epidemiology and Escherichia coli.

His most cited work include:

  • Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella (604 citations)
  • Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins (536 citations)
  • Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City (418 citations)

What are the main themes of his work throughout his whole career to date?

Microbiology, Antibiotics, Klebsiella pneumoniae, Acinetobacter baumannii and Antibiotic resistance are his primary areas of study. The various areas that he examines in his Microbiology study include Virology and Enterobacteriaceae, Escherichia coli. His Antibiotics research is multidisciplinary, incorporating elements of Plasmid and Beta-lactamase.

His study looks at the intersection of Klebsiella pneumoniae and topics like Klebsiella with Cephalosporin. His Acinetobacter baumannii study which covers Polymyxin B that intersects with Polymyxin and Imipenem. His Antibiotic resistance research integrates issues from Antimicrobial and Intensive care medicine.

He most often published in these fields:

  • Microbiology (89.23%)
  • Antibiotics (37.69%)
  • Klebsiella pneumoniae (26.92%)

What were the highlights of his more recent work (between 2011-2021)?

  • Microbiology (89.23%)
  • Klebsiella pneumoniae (26.92%)
  • Escherichia coli (19.23%)

In recent papers he was focusing on the following fields of study:

Carl Urban mainly focuses on Microbiology, Klebsiella pneumoniae, Escherichia coli, Antibiotics and Drug resistance. His work deals with themes such as Enterobacteriaceae and Acinetobacter baumannii, which intersect with Microbiology. His research integrates issues of Gerontology, Carbapenem and Virology in his study of Klebsiella pneumoniae.

The concepts of his Escherichia coli study are interwoven with issues in Urine and Beta. The Antibiotics study combines topics in areas such as Internal medicine, Methicillin-resistant Staphylococcus aureus and Daptomycin. His biological study spans a wide range of topics, including Traditional medicine, MEDLINE and Antibiogram.

Between 2011 and 2021, his most popular works were:

  • Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli (206 citations)
  • Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli (206 citations)
  • Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City (104 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Bacteria
  • Internal medicine

Carl Urban spends much of his time researching Microbiology, Drug resistance, Escherichia coli, Antibiotic resistance and Klebsiella pneumoniae. Multiple drug resistance and Antibiotics are among the areas of Microbiology where Carl Urban concentrates his study. Drug resistance is closely attributed to Antimicrobial in his work.

His Escherichia coli research includes elements of Molecular epidemiology and Pulsed-field gel electrophoresis. Carl Urban has researched Antibiotic resistance in several fields, including Internal medicine and Epidemiology. His Klebsiella pneumoniae research incorporates themes from Enterobacteriaceae, Acinetobacter baumannii and Virology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Class Restriction of Cephalosporin Use to Control Total Cephalosporin Resistance in Nosocomial Klebsiella

James J. Rahal;Carl Urban;David Horn;Katherine Freeman.
JAMA (1998)

970 Citations

Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins

Kenneth S. Meyer;Carl Urban;Janet A. Eagan;Barbara J. Berger.
Annals of Internal Medicine (1993)

848 Citations

Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City

Patricia A. Bradford;Simona Bratu;Carl Urban;Melissa Visalli.
Clinical Infectious Diseases (2004)

652 Citations

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

E.S Go;C Urban;J Burns;N Mariano.
The Lancet (1994)

514 Citations

Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.

Carl Urban;Sorana Segal-Maurer;James J. Rahal.
Clinical Infectious Diseases (2003)

308 Citations

Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli

James R Johnson;Veronika Tchesnokova;Brian D Johnston;Connie Clabots.
The Journal of Infectious Diseases (2013)

292 Citations

Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus.

H de Lencastre;A M Sá Figueiredo;C Urban;J Rahal.
Antimicrobial Agents and Chemotherapy (1991)

257 Citations

In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii

Jimmy Yoon;Carl Urban;Christian Terzian;Noriel Mariano.
Antimicrobial Agents and Chemotherapy (2004)

235 Citations

Effect of Sulbactam on Infections Caused by Imipenem-Resistant Acinetobacter calcoaceticus Biotype anitratus

Carl Urban;Eddie Go;Noriel Mariano;Barbara J. Berger.
The Journal of Infectious Diseases (1993)

227 Citations

Safety of High-Dose Intravenous Daptomycin Treatment: Three-Year Cumulative Experience in a Clinical Program

D. A. Figueroa;E. Mangini;M. Amodio-Groton;B. Vardianos.
Clinical Infectious Diseases (2009)

209 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Carl Urban

James R. Johnson

James R. Johnson

University of Minnesota

Publications: 89

David L. Paterson

David L. Paterson

University of Queensland

Publications: 68

Brian D. Johnston

Brian D. Johnston

University of Minnesota

Publications: 53

Yehuda Carmeli

Yehuda Carmeli

Tel Aviv University

Publications: 43

Robert A. Bonomo

Robert A. Bonomo

Case Western Reserve University

Publications: 43

Yohei Doi

Yohei Doi

University of Pittsburgh

Publications: 42

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 40

Michael J. Rybak

Michael J. Rybak

Wayne State University

Publications: 39

Louis B. Rice

Louis B. Rice

Brown University

Publications: 31

Matthew E. Falagas

Matthew E. Falagas

Alfa Institute of Biomedical Sciences

Publications: 30

David M. Livermore

David M. Livermore

University of East Anglia

Publications: 30

Karen Bush

Karen Bush

Indiana University

Publications: 29

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 28

Hermínia de Lencastre

Hermínia de Lencastre

Rockefeller University

Publications: 28

Paul Thuras

Paul Thuras

University of Minnesota

Publications: 28

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 28

Trending Scientists

Kilian Q. Weinberger

Kilian Q. Weinberger

Cornell University

Aleix M. Martinez

Aleix M. Martinez

The Ohio State University

Alessandro Moschitti

Alessandro Moschitti

Amazon (United States)

Emanuel Todorov

Emanuel Todorov

University of Washington

Khalil Hanna

Khalil Hanna

Institut Universitaire de France

Joseph E Greene

Joseph E Greene

University of Illinois at Urbana-Champaign

Michael M. Fogler

Michael M. Fogler

University of California, San Diego

Rodney Andrews

Rodney Andrews

University of Kentucky

Jian Yu

Jian Yu

University of Pittsburgh

Jules M. Blais

Jules M. Blais

University of Ottawa

Jan Andersson

Jan Andersson

Karolinska Institute

Theo A. H. Doreleijers

Theo A. H. Doreleijers

Amsterdam UMC

Rosanna E. Guadagno

Rosanna E. Guadagno

Stanford University

Merit Cudkowicz

Merit Cudkowicz

Harvard University

Stephen Harrison

Stephen Harrison

University of Manchester

Packianathan Chelladurai

Packianathan Chelladurai

The Ohio State University

Something went wrong. Please try again later.